表紙
市場調查報告書

發炎性腸道疾病 (IBD) 治療市場 - 分析,佔有率,趨勢,規模,預測:2020年∼2026年

Inflammatory Bowel Disease Treatment Market, By Type, By Route of Administration, By Distribution Channel, and By Geography - Analysis, Share, Trends, Size, & Forecast From 2020 - 2026

出版商 AnalystView Market Insights 商品編碼 941400
出版日期 內容資訊 英文 154 Pages
商品交期: 2-3個工作天內
價格
發炎性腸道疾病 (IBD) 治療市場 - 分析,佔有率,趨勢,規模,預測:2020年∼2026年 Inflammatory Bowel Disease Treatment Market, By Type, By Route of Administration, By Distribution Channel, and By Geography - Analysis, Share, Trends, Size, & Forecast From 2020 - 2026
出版日期: 2020年06月01日內容資訊: 英文 154 Pages
簡介

發炎性腸道疾病 (IBD) 治療市場,2019年前預計將達到158億7000萬美元,2020年∼2026年的預測期間內,預計將以年複合成長率4.1%的速度成長。

本報告提供全球發炎性腸道疾病 (IBD) 治療市場相關調查分析,提供市場概要,市場動態,各市場區隔的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 發炎性腸道疾病 (IBD) 治療市場概要

  • 調查範圍
  • 前提條件與調查手法

第2章 摘要整理

第3章 發炎性腸道疾病 (IBD) 治療主要的市場趨勢

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 市場未來趨勢

第4章 發炎性腸道疾病 (IBD) 治療產業分析

  • 波特的五力分析
  • 行銷策略分析
  • 成長預測製圖
  • 法律規範分析
  • COVID-19的影響分析

第5章 發炎性腸道疾病 (IBD) 治療市場形勢

  • 市場佔有率分析
  • 主要創新者
  • 明細資料:各主要製造商

第6章 發炎性腸道疾病 (IBD) 治療市場:各給藥途徑

  • 概要
  • 口服
  • 注射劑

第7章 發炎性腸道疾病 (IBD) 治療市場:各類型

  • 概要
  • 克隆氏症
  • 潰瘍性大腸炎
  • 其他

第8章 發炎性腸道疾病 (IBD) 治療市場:各銷售管道

  • 概要
  • 零售藥局
  • 醫院藥局
  • 線上藥局

第9章 發炎性腸道疾病 (IBD) 治療市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第10章 主要供應商分析

  • Pfizer Inc.
  • AbbVie Inc.
  • Cosmo Pharmaceuticals
  • UCB S.A.
  • Innovate Biopharmaceuticals
  • Gilead Sciences
  • Celgene Corporation
  • Celltrion Healthcare Co., Ltd.
  • Johnson & Johnson Services Inc.
  • Takeda Pharmaceutical Company Limited

第11章 分析師的見解

第12章 附錄

目錄

REPORT HIGHLIGHT

Inflammatory Bowel Disease (IBD) Treatment market was valued at USD 15.87 billion by 2019, growing with 4.1% CAGR during the forecast period, 2020-2026

Market Dynamics

A rise in the number of drugs available in clinical tests, growing prevalence of inflammatory bowel disease (IBD), and rising government initiatives related to the analysis of the causes and effective novel drug developments are the major factors driving the growth of global IBD treatment market. In addition, the high prevalence of and growing occurrence of ulcerative colitis and Chron's disease are likely to create growth opportunities in the IBD treatment market in the projected timeframe. However, stringent drug regulatory policies and lack of treatment effectiveness are predicted to impede the market growth in the coming future.

TYPES TAKEAWAY

The Crohn's disease type segment accounted for the majority of share in 2019 and is expected to rise at an impressive growth rate during the forecast period. This growth is primarily owing to the growing prevalence of the condition. As per a published article in 2018 in Jobson Medical Information LLC, the occurrence of Chron's disease was found to be approximately 3.1 to 14.6 cases per 100,000 people each year and the incidence in the U.S. was around 201 cases per 100,000 adults. On the other hand, the ulcerative colitis segment is expected to grow at the fastest rate throughout the forecast majorly due to presence of strong pipeline for the treatment of ulcerative colitis.

Route of Distribution Takeaway

The injectables route of administration segment is considered to be the largest due to its efficacy. Additionally, the development of biosimilars such as Inflectra is likely to boost the segmental market growth. Along with injectables, the oral route segment is projected to be the fastest-growing market by 2030 owing to the presence of strong pipeline products. The ASAs sub-segment of the oral route of administration subjugated the market in 2019 and the AK inhibitors sub-segment is estimated to grow at the fastest pace during the period of forecast.

Distribution Channel Takeaway

By distribution channel, the hospital pharmacy segment including both out-patient and in-patient subjugated the market in 2018 and is predicted to grow exponentially throughout the forecast. This is majorly owing to the rising prevalence of ulcerative colitis and Crohn's disease coupled with a growing total number of hospitalizations all across the globe. On the other hand, the online pharmacy is predicted to be the fastest-growing segmental market by the end of 2030. The increasing demand and rising trend of online purchasing are contributing to the growth of online pharmacy segment. In addition, customers find online pharmacy beneficial due to the availability of various offers and discounts.

REGIONAL TAKEAWAY

Presently, the North America market for IBD treatment is playing a dominant role owing to the presence of major market players and sophisticated healthcare infrastructure. The region is expected to lead the market during the period of forecast due to rising prevalence of Chron's diseases & ulcerative colitis and the growing increasing geriatric population in the U.S. On the other hand, the Asia Pacific region is estimated to grow at the fastest pace by the end of 2030 due to increasing product approvals in this region.

Key players of the market include:

  • Pfizer Inc.
  • AbbVie Inc.
  • Cosmo Pharmaceuticals
  • UCB S.A.
  • Innovate Biopharmaceuticals
  • Gilead Sciences
  • Celgene Corporation
  • Celltrion Healthcare Co., Ltd.
  • Johnson & Johnson Services Inc.
  • Takeda Pharmaceutical Company Limited

The market size and forecast for each segment and sub-segments has been considered as below:

  • Historical Year - 2015 to 2018
  • Base Year - 2019
  • Estimated Year - 2020
  • Projected Year - 2026

TARGET AUDIENCE

  • Traders, Distributors, and Suppliers
  • Manufacturers
  • Government and Regional Agencies
  • Research Organizations
  • Consultants
  • Distributors

Scope of the Report

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION

  • Oral
  • 5-Aminosalicylic Acid
  • Corticosteroids
  • Janus Kinase (JAK) Inhibitors
  • Others
  • Injectable
  • Tumor Necrosis Factor (TNF) Inhibitors
  • Interleukin inhibitors
  • Anti-integrin
  • Others

GLOBAL INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET, BY TYPE

  • Chron's Disease
  • Ulcerative Colitis
  • Others

GLOBAL INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET, BY DISTRIBUTION CHANNEL

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
  • Others

GLOBAL INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Singapore
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Rest of MEA

TABLE OF CONTENT

1. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Route of Administration
    • 2.1.2. Market Snippet by Type
    • 2.1.3. Market Snippet by Distribution Channel
    • 2.1.4. Market Snippet by Region
  • 2.2. Competitive Insights

3. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT INDUSTRY STUDY

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis
  • 4.5. COVID-19 Impact Analysis
    • 4.5.1. Pre-COVID-19 Impact Analysis
    • 4.5.2. Post-COVID-19 Impact Analysis

5. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET LANDSCAPE

  • 5.1. Market Share Analysis
  • 5.2. Key Innovators
  • 5.3. Breakdown Data, by Key manufacturer
    • 5.3.1. Established Player Analysis
    • 5.3.2. Emerging Player Analysis

6. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET - BY ROUTE OF ADMINISTRATION

  • 6.1. Overview
    • 6.1.1. Segment Share Analysis, By Route of Administration, 2019 & 2026 (%)
  • 6.2. Oral
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 6.2.3. 5-Aminosalicylic Acid
      • 6.2.3.1. Overview
      • 6.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 6.2.4. Corticosteroids
      • 6.2.4.1. Overview
      • 6.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 6.2.5. Janus Kinase (JAK) Inhibitors
      • 6.2.5.1. Overview
      • 6.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 6.2.6. Others
      • 6.2.6.1. Overview
      • 6.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.3. Injectable
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 6.3.3. Tumor Necrosis Factor (TNF) Inhibitors
      • 6.3.3.1. Overview
      • 6.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 6.3.4. Interleukin inhibitors
      • 6.3.4.1. Overview
      • 6.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 6.3.5. Anti-integrin
      • 6.3.5.1. Overview
      • 6.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 6.3.6. Others
      • 6.3.6.1. Overview
      • 6.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

7. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET - BY TYPE

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2019 & 2026 (%)
  • 7.2. Chron's Disease
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.3. Ulcerative Colitis
    • 7.3.1. Overview
    • 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.4. Others
    • 7.4.1. Overview
    • 7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

8. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET - BY DISTRIBUTION CHANNEL

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Distribution Channel, 2019 & 2026 (%)
  • 8.2. Retail Pharmacy
    • 8.2.1. Overview
    • 8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.3. Hospital Pharmacy
    • 8.3.1. Overview
    • 8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.4. Online Pharmacy
    • 8.4.1. Overview
    • 8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET- BY GEOGRAPHY

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
    • 9.2.6. North America Market Size and Forecast, By Route of Administration, 2015 - 2026 (US$ Million)
    • 9.2.7. U.S.
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.2.8. Canada
      • 9.2.8.1. Overview
      • 9.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
    • 9.3.6. Europe Market Size and Forecast, By Route of Administration, 2015 - 2026 (US$ Million)
    • 9.3.7. Germany
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.8. Italy
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.9. United Kingdom
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.10. France
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.11. Rest of Europe
      • 9.3.11.1. Overview
      • 9.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
    • 9.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2015 - 2026 (US$ Million)
    • 9.4.7. India
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.8. China
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.9. Japan
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.10. South Korea
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.11. Rest of APAC
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
    • 9.5.6. Latin America Market Size and Forecast, By Route of Administration, 2015 - 2026 (US$ Million)
    • 9.5.7. Brazil
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.5.8. Mexico
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.5.9. Argentina
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
    • 9.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2015 - 2026 (US$ Million)
    • 9.6.7. Saudi Arabia
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.6.8. United Arab Emirates
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

10. KEY VENDOR ANALYSIS

  • 10.1. Pfizer Inc.
    • 10.1.1. Company Snapshot
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Strategic Initiatives
  • 10.2. AbbVie Inc.
  • 10.3. Cosmo Pharmaceuticals
  • 10.4. UCB S.A.
  • 10.5. Innovate Biopharmaceuticals
  • 10.6. Gilead Sciences
  • 10.7. Celgene Corporation
  • 10.8. Celltrion Healthcare Co., Ltd.
  • 10.9. Johnson & Johnson Services Inc.
  • 10.10. Takeda Pharmaceutical Company Limited

11. 360 DEGREE ANALYSTVIEW

12. APPENDIX

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Inflammatory Bowel Disease (IBD) Treatment market: Route of Administration Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Inflammatory Bowel Disease (IBD) Treatment market, by Route of Administration 2015-2026 (USD Million)
  • TABLE Inflammatory Bowel Disease (IBD) Treatment market: Type Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Inflammatory Bowel Disease (IBD) Treatment market, by Type 2015-2026 (USD Million)
  • TABLE Inflammatory Bowel Disease (IBD) Treatment market: Distribution Channel Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Inflammatory Bowel Disease (IBD) Treatment market, by Distribution Channel 2015-2026 (USD Million)
  • TABLE Inflammatory Bowel Disease (IBD) Treatment market: Regional snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Inflammatory Bowel Disease (IBD) Treatment market, by Region 2015-2026 (USD Million)
  • TABLE North America Inflammatory Bowel Disease (IBD) Treatment market, by Country, 2015-2026 (USD Million)
  • TABLE North America Inflammatory Bowel Disease (IBD) Treatment market, by Type, 2015-2026 (USD Million)
  • TABLE North America Inflammatory Bowel Disease (IBD) Treatment market, by Distribution Channel, 2015-2026 (USD Million)
  • TABLE North America Inflammatory Bowel Disease (IBD) Treatment market, by Route of Administration, 2015-2026 (USD Million)
  • TABLE Europe Inflammatory Bowel Disease (IBD) Treatment market, by country, 2015-2026 (USD Million)
  • TABLE Europe Inflammatory Bowel Disease (IBD) Treatment market, by Type, 2015-2026 (USD Million)
  • TABLE Europe Inflammatory Bowel Disease (IBD) Treatment market, by Distribution Channel, 2015-2026 (USD Million)
  • TABLE Europe Inflammatory Bowel Disease (IBD) Treatment market, by Route of Administration, 2015-2026 (USD Million)
  • TABLE Asia Pacific Inflammatory Bowel Disease (IBD) Treatment market, by country, 2015-2026 (USD Million)
  • TABLE Asia Pacific Inflammatory Bowel Disease (IBD) Treatment market, by Type, 2015-2026 (USD Million)
  • TABLE Asia Pacific Inflammatory Bowel Disease (IBD) Treatment market, by Distribution Channel, 2015-2026 (USD Million)
  • TABLE Asia Pacific Inflammatory Bowel Disease (IBD) Treatment market, by Route of Administration, 2015-2026 (USD Million)
  • TABLE Latin America Inflammatory Bowel Disease (IBD) Treatment market, by country, 2015-2026 (USD Million)
  • TABLE Latin America Inflammatory Bowel Disease (IBD) Treatment market, by Route of Administration, 2015-2026 (USD Million)
  • TABLE Latin America Inflammatory Bowel Disease (IBD) Treatment market, by Type, 2015-2026 (USD Million)
  • TABLE Latin America Inflammatory Bowel Disease (IBD) Treatment market, by Distribution Channel, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment market, by country, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment market, by Type, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment market, by Distribution Channel, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment market, by Route of Administration, 2015-2026 (USD Million)

List of Figures

  • FIGURE Inflammatory Bowel Disease (IBD) Treatment market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2018
  • FIGURE Route of Administration segment market share analysis, 2019 & 2026
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Oral segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE 5-Aminosalicylic Acid segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Corticosteroids segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Janus Kinase (JAK) Inhibitors segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Injectable segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Tumor Necrosis Factor (TNF) Inhibitors segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Interleukin inhibitors segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Anti-integrin segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Type segment market share analysis, 2019 & 2026
  • FIGURE Type segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Chron's Disease segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Ulcerative Colitis segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Distribution Channel segment market share analysis, 2019 & 2026
  • FIGURE Distribution Channel segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Retail Pharmacy segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Hospital Pharmacy segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Online Pharmacy market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Regional segment market share analysis, 2019 & 2026
  • FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE North America Inflammatory Bowel Disease (IBD) Treatment market share and leading players, 2018
  • FIGURE Europe Inflammatory Bowel Disease (IBD) Treatment market share and leading players, 2018
  • FIGURE Asia Pacific Inflammatory Bowel Disease (IBD) Treatment market share and leading players, 2018
  • FIGURE Latin America Inflammatory Bowel Disease (IBD) Treatment market share and leading players, 2018
  • FIGURE Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment market share and leading players, 2018
  • FIGURE North America Inflammatory Bowel Disease (IBD) Treatment market share analysis by country, 2018
  • FIGURE U.S. Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Canada Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Europe Inflammatory Bowel Disease (IBD) Treatment market share analysis by country, 2018
  • FIGURE Germany Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Spain Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Italy Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE UK Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE France Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of the Europe Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Asia Pacific Inflammatory Bowel Disease (IBD) Treatment market share analysis by country, 2018
  • FIGURE India Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE China Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Japan Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE South Korea Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Singapore Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of APAC Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Inflammatory Bowel Disease (IBD) Treatment market share analysis by country, 2018
  • FIGURE Brazil Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Mexico Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Argentina Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of LATAM Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment market share analysis by country, 2018
  • FIGURE Saudi Arabia Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE United Arab Emirates Inflammatory Bowel Disease (IBD) Treatment market size, forecast and trend analysis, 2015 to 2026 (USD Million)